Double-blind randomized trial of nicotinamide on early-onset diabetes.
To determine the efficacy of nicotinamide in inducing remission in early-onset insulin-dependent diabetes mellitus. This study was a double-blind, randomized clinical trial. Nicotinamide failed to induce remission or differences on beta-cell secretion between the two groups.